Evidence map›Paper›PMID 31326608›Full record

ArticleBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation2019

Gut Colonization Preceding Mucosal Barrier Injury Bloodstream Infection in Pediatric Hematopoietic Stem Cell Transplantation Recipients.

Matthew S Kelly, Doyle V Ward, Christopher J Severyn, Mehreen Arshad, Sarah M Heston, Kirsten Jenkins, Paul L Martin, Lauren McGill, Andre Stokhuyzen, Shakti K Bhattarai and 2 more

Abstract read
In one paragraph

Article in Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Omnigene-GutAMB Express · 2024
    Article
  11. Article
  12. Understanding the influence of the microbiome on childhood infections.Expert review of anti-infective therapy · 2024
    Review
  13. The Microbiome and Pediatric Transplantation.Journal of the Pediatric Infectious Diseases Society · 2024
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Matthew S KellyDivision of Pediatric Infectious Diseases, Duke University Medical Center, Durham, North Carolina. Electronic address: matthew.kelly@duke.edu.
Doyle V WardCenter for Microbiome Research, University of Massachusetts Medical School, Worcester, Massachusetts; Department of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, Massachusetts.
Christopher J SeverynDivision of Pediatric Hematology and Oncology, Lucile Packard Children's Hospital, Palo Alto, California.
Mehreen ArshadDivision of Pediatric Infectious Diseases, Duke University Medical Center, Durham, North Carolina.
Sarah M HestonDivision of Pediatric Infectious Diseases, Duke University Medical Center, Durham, North Carolina.
Kirsten JenkinsDivision of Pediatric Infectious Diseases, Duke University Medical Center, Durham, North Carolina.
Paul L MartinDivision of Pediatric Blood and Marrow Transplant, Duke University Medical Center, Durham, North Carolina.
Lauren McGillDivision of Pediatric Blood and Marrow Transplant, Duke University Medical Center, Durham, North Carolina.
Andre StokhuyzenDivision of Pediatric Blood and Marrow Transplant, Duke University Medical Center, Durham, North Carolina.
Shakti K BhattaraiDepartment of Biology, University of Massachusetts Dartmouth, North Dartmouth, Massachusetts.
Vanni BucciDepartment of Biology, University of Massachusetts Dartmouth, North Dartmouth, Massachusetts.
Patrick C SeedDivision of Pediatric Infectious Diseases, Ann & Robert H. Lurie Children's Hospital, Chicago, Illinois.

Funding

Antibacterial Resistance Leadership Group (ARLG)UM1AI104681 · NIAID · DUKE UNIVERSITY · PI Vance G. Fowler, Henry F HENRY CHAMBERS · 2013 to 2026
$180.8M
Technology CoreU19AI135964 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI JUSTIN B. STARREN · 2018 to 2026
$24.7M
Training in Pediatric Nonmalignant Hematology and Stem Cell BiologyT32DK098132 · NIDDK · STANFORD UNIVERSITY · PI SAKAMOTO, KATHLEEN M · 2014 to 2022
$1.9M
Nasopharyngeal Microbiome and Risk of Bacterial Pathogen Colonization in InfantsK23AI135090 · NIAID · DUKE UNIVERSITY · PI KELLY, MATTHEW SCOTT · 2018 to 2022
$860k
Mathematical modeling from metagenomics - minimizing risk of enteric infectionsR15AI112985 · NIAID · UNIVERSITY OF MASSACHUSETTS DARTMOUTH · PI BUCCI, VANNI · 2015 to 2015
$465k
NIAID NIH HHS K23 AI135090NIAID NIH HHS R15 AI112985NIAID NIH HHS U19 AI135964NIAID NIH HHS UM1 AI104681NIDDK NIH HHS T32 DK098132
6 · The paper itself

Abstract

The gastrointestinal tract is the predicted reservoir for most bloodstream infections (BSIs) after hematopoietic stem cell transplantation (HSCT). Whole-genome sequencing and comparative genomics have the potential to improve our understanding of the dynamics of gut colonization that precede BSI in HSCT recipients. Within a prospective cohort study of children (age <18 years) undergoing HSCT, 9 subjects met criteria for mucosal barrier injury BSI. We performed whole-genome sequencing of the blood culture isolate and weekly fecal samples preceding the BSI to compare the genetic similarity of BSI isolates to fecal strains. We evaluated temporal associations between antibiotic exposures and the abundances of BSI strains in the gut microbiota and correlated the detection of antibiotic resistance genes with the phenotypic antibiotic resistance of these strains. The median patient age was 2.6 years, and 78% were male. BSIs were caused by Escherichia coli (n = 5), Enterococcus faecium (n = 2), Enterobacter cloacae (n = 1), and Rothia mucilaginosa (n = 1). In the 6 BSI episodes with evaluable comparative genomics, the fecal strains were identical to the blood culture isolate (>99.99% genetic similarity). Gut domination by these strains preceded only 4 of 7 E. coli or E. faecium BSIs by a median of 17 days (range, 6 to 21 days). Increasing abundances of the resulting BSI strains in the gut microbiota were frequently associated with specific antibiotic exposures. E. cloacae and R. mucilaginosa were not highly abundant in fecal samples preceding BSIs caused by these species. The detection of antibiotic resistance genes for β-lactam antibiotics and vancomycin predicted phenotypic resistance in BSI strains. Bacterial strains causing mucosal barrier injury BSI in pediatric HSCT recipients were observed in the gut microbiota before BSI onset, and changes in the abundances of these strains within the gut preceded most BSI episodes. However, frequent sampling of the gut microbiota and sampling of other ecological niches is likely necessary to effectively predict BSI in HSCT recipients.

Indexed as

BacteriaBacterial InfectionsDrug Resistance, BacterialGastrointestinal MicrobiomeHematopoietic Stem Cell TransplantationIntestinal MucosaAllograftsChildChild, PreschoolFemaleHumansMaleProspective StudiesBloodstream infectionHematopoietic stem cell transplantationMicrobiome

Identifiers

PMID31326608
PMCPMC6861666

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.